Initial hospital pulse pressure and cardiovascular outcomes in acute coronary syndrome  by El-Menyar, Ayman et al.
Archives of Cardiovascular Disease (2011) 104, 435—443
CLINICAL RESEARCH
Initial hospital pulse pressure and cardiovascular
outcomes in acute coronary syndrome
Pression pulsée à la phase initiale d’une hospitalisation et évènements
cardiovasculaires au décours d’un syndrome coronaire aigu
Ayman El-Menyara, Mohammad Zubaidb,
Wael Almahmeedc, Muath Alanbaeid, Wafa Rashede,
Awad Al Qahtania, Rajvir Singhf, Shahid Zubair g,
Jassim Al Suwaidia,∗
a Department of Cardiology and Cardiovascular Surgery, Hamad General Hospital (HMC), P.O.
Box 3050, Doha, Qatar
b Faculty of Medicine, Kuwait University, Kuwait
c Sheikh Khalifa Medical City, United Arab Emirates
d Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait
e Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait
f Medical Research Centre, Hamad Medical Corporation, Qatar
g Department of Medicine, Kuwait Oil Company Hospital, Kuwait
Received 7 December 2010; received in revised form 9 May 2011; accepted 9 May 2011
KEYWORDS
Pulse pressure;
Acute coronary
syndrome;
Mortality
Summary
Background.— The association between admission pulse pressure (PP) and cardiovascular out-
comes in acute coronary syndrome (ACS) is not well deﬁned.
Aim.— To explore the prognostic value of initial PP in ST-segment elevation myocardial infarc-
tion (STEMI) and non-ST elevation ACS (NSTE-ACS).
Methods.— Over a 5-month period in 2007, 6704 consecutive patients with ACS were catego-
rized into ﬁve groups according to initial PP: P1, PP ≤ 0; P2, PP 31—40; P3, PP 41—50; P4, PP
51—60; P5, PP > 60mmHg. Patient characteristics and in-hospital outcomes were analysed.
Results.— Mean PP was lower in men versus women (55± 19 vs. 61± 22), young versus old
(53± 17 vs. 59± 21), STEMI vs. NSTE-ACS (51± 18 vs. 60± 18) and patients who died versus
survived (46± 22 vs. 57± 19mmHg) (P < 0.001 for all). Most patients with low PP had a high
Global Registry of Acute Coronary Events risk score. Compared with P5, crude odds ratios
(ORs) (95% conﬁdence intervals) for death were: P1, 9 (5.78—13.35); P2, 3 (1.71—4.06); P3,
Abbreviations: ACS, acute coronary syndrome; BP, blood pressure; CI, conﬁdence interval; DBP, diastolic blood pressure; HF, heart
failure; MAP, mean arterial pressure; MI, myocardial infarction; NSTE-ACS, non-ST elevation acute coronary syndrome; PP, pulse pressure;
SBP, systolic blood pressure; SD, standard deviation; STEMIST, segment elevation myocardial infarction.
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1.5 (1.01—2.49); P4, 0.90 (0.51—1.58). After adjustment, low PP was associated with high
mortality and stroke rates in ACS (adjusted ORs 7.5 [3.77—14.72] and 4.5 [1.20—18.88], respec-
tively), high rates of recurrent ischaemia in NSTE-ACS (adjusted OR 2.8 [1.52—5.22]) and a high
heart failure rate in STEMI (adjusted OR 2.1 [1.18—3.76]). Women with low PP had a higher
mortality rate than men.
Conclusion.— In ACS, all blood pressure variables were signiﬁcantly correlated. Low PP was an
independent predictor for stroke and mortality in overall ACS. Although PP was not superior to
systolic blood pressure, only low PP was an independent predictor for recurrent ischaemia in
NSTE-ACS.
© 2011 Elsevier Masson SAS. All rights reserved.
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Résumé
Justiﬁcation.— L’association entre la pression pulsée à l’admission et les évènements cardio-
vasculaires au décours d’un syndrome coronaire aigu n’est pas bien connue.
Objectifs.— Évaluer l’impact pronostique de la pression pulsée à l’admission chez des patients
ayant un syndrome coronaire aigu avec (STEMI) ou sans sus décalage du segment ST (NSTE-ACS).
Méthode.— Pendant une durée de cinq mois, 6704 patients consécutifs ayant un syndrome coro-
naire aigu ont été répartis en groupes en fonction de la pression pulsée à l’admission : P1 pression
pulsée≤ 30, P2 PP 31—40, P3 PP 51—60, P5 PP > 60mmHg. Les caractéristiques de base de ces
patients et les évènements cardiovasculaires en phase hospitalière ont été analysés.
Résultats.— La pression pulsée moyenne était signiﬁcativement moindre chez les hommes
comparativement aux femmes (59± 19 vs. 61± 22mmHg), chez les patients jeunes compa-
rativement aux sujets âgés (53± 17 vs. 59± 21mmHg), en cas de STEMI versus NSTE-ACS
(51± 18 versus 60± 18mmHg) et chez les patients décédés comparativement aux survivants
(46± 22 vs. 57± 19mmHg) (p < 0,001 pour l’ensemble de ces variables). La majorité des patients
ayant une pression pulsée basse avaient un score GRACE élevé. Comparativement au groupe P5,
l’odd ratio non ajusté (ORs) (IC 95 %) était le suivant pour les décès P1, 9 (IC 95%, 5,78—13,35) ;
P2, 3 (IC 95%, 1,71—4,06) ; P3, 1,5 (IC 95%, 1,01—2,49) ; P4 0,90 IC 95%, (0,51—1,58). Après
ajustement, la pression pulsée est associée à une surmortalité de risque accru (ORs 7,5, IC 95%
3,77—14,72) et à un taux accru d’AVC 4,5 (1,20—18,88), avec un taux plus élevé de récidive
d’ischémie dans le syndrome coronaire aigu sans sus décalage du ST, NSTE-ACS (OR ajusté 2,8
[IC 95%, 1,52—5,22]) et un taux accru d’insufﬁsance cardiaque chez les patients ayant un STEMI
(odd ratio 2,1 [IC 95%, 1,18—3,76]). Les femmes ayant une pression pulsée moindre avaient un
taux de mortalité augmenté comparativement aux autres.
Conclusion.— Dans le syndrome coronaire aigu, toutes les variables dérivées de la pres-
sion artérielles sont signiﬁcativement corrélées. Une pression pulsée basse est un prédicteur
indépendant du risque d’AVC et de surmortalité quel que soit leur type de syndrome coronaire
aigu. Bien que la pression pulsée ne soit pas supérieure à la pression artérielle systolique, seule
une pression pulsée basse est un prédicteur indépendant de la récidive ischémique dans les
syndromes coronaires aigus sans sus décalage de ST.
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ackground
rterial blood pressure (BP) variables that are easily obtain-
ble at the bedside include systolic BP (SBP), diastolic BP
DBP), mean arterial pressure (MAP) and pulse pressure
PP). Although these BP variables are of clinical impor-
ance in many cardiovascular disorders, the best predictor
o consider in clinical practice is not well deﬁned [1]. PP
rises as a consequence of the episodic nature of cardiac
ontraction and the properties of the arterial circulation;
t reﬂects stiffness of the aorta and large arteries, and
ulse wave velocity [2,3]. Recently, PP has been identiﬁed
s a more powerful prognostic predictor of cardiovascular
vents than SBP and DBP in selected populations [2—10].
ata from the population-based Framingham Heart Study
howed that neither SBP nor DBP was superior to high PP in
n
M
(s droits réservés.
redicting coronary heart disease risk in middle-aged and
lderly patients [6]. However, most of these ﬁndings were
xtracted from studies that evaluated the impact of PP in
on-acute cardiovascular situations. Therefore, data on the
rognostic inﬂuence of the initial hospital recording of the
ulsatile components of the arterial BP wave (i.e. PP) in
cute coronary events is lacking. The only available reports
n PP after acute myocardial infarction (MI) were pro-
ided for a particular subgroup of high-risk patients, namely
hose with impaired left ventricular function [11—13]. The
resent study explores data from the Gulf Registry of Acute
oronary Events (Gulf RACE) to assess whether low versus
igh PP measured on admission plays an additional prog-
ostic role in patients presenting with ST-segment elevation
I (STEMI) and non-ST elevation acute coronary syndrome
NSTE-ACS).
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Methods
The data are derived from a prospective, multicentre,
observational study of the Gulf RACE. In 2007 and for
5months, the Gulf RACE investigators recruited 6704 con-
secutive acute coronary syndrome (ACS) patients from 64
hospitals in six Middle Eastern countries (Bahrain, Kuwait,
Qatar, Oman, United Arab Emirates and Yemen). The study
received ethical approval from the institutional ethical bod-
ies in all participating countries. The rationale and details
of the Gulf RACE have been described previously [14—16].
All participating centres were committed by written consent
to include every consecutive patient with ACS. All patients
gave informed consent to participate and care was taken to
ensure data anonymity. Data were collected on record forms
by the treating physicians. Completed data sheets were sent
to the central data processing centre for uniform monitor-
ing and registration. The primary outcome was in-hospital
mortality rate. The secondary outcomes included recurrent
myocardial ischaemia, heart failure (HF) and stroke.
Brachial PP was used as a marker of the pulsatile
component of BP. A single BP measurement was taken
with a sphygmomanometer at the time of presentation in
the supine position; PP was calculated as the difference
between SBP and DBP; MAP was calculated as two-thirds
DBP plus one-third SBP. To explore the relationship between
in-hospital outcome and arterial pressure indices, BP val-
ues were analysed as continuous and categorical variables.
In the latter case, BP values were grouped in 10-mmHg
classes according to the following cut-off values: P1, ≤ 30;
P2, 31—40; P3, 41—50; P4, 51—60; P5, > 60mmHg [11].
Brieﬂy, diagnosis of the different types of ACS and deﬁni-
tions of data variables were based on the American College
of Cardiology clinical data standard [14]. For the purpose of
this report, ST-segment elevation MI and left bundle branch
block MI were grouped together and called STEMI; non-ST-
segment elevation MI and unstable angina were grouped
together and called NSTE-ACS. An attempt was made to
include everyone with a ﬁnal diagnosis of ACS and there were
no exclusion criteria [15—17].
Statistical analysis
Data are presented as proportions, medians or
means± standard deviations (SDs) as appropriate. Dif-
ferences in categorical variables between respective
comparison groups were analysed using the chi-square
test. The continuous variables were analysed using one-
way analysis of variance. The multivariable model for
the predictors of the in-hospital outcomes included the
following potential covariates: age, sex, diabetes melli-
tus, hypertension, ejection fraction, troponin T, aspirin,
clopidogrel, glycoprotein inhibitors, beta-blockers and
angiotensin-converting enzyme inhibitors. To assess the
linear relationship among some or all of the independent
variables in the regression model, collinearity was tested
by calculating the correlation coefﬁcient among the BP
variables. Owing to collinearity between BP variables, only
PP and SBP variables were taken into the multivariable
analysis. All p values were two-sided tailed. P values < 0.05
were considered signiﬁcant. In a subanalysis, PP patients
were divided into two groups (≤ 30 vs. > 30mmHg) for
m
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omparing the mortality rate in each group, stratiﬁed by
he admission Killip class. All data analyses were carried
ut using the Statistical Package for Social Sciences, version
4 (SPSS Inc., Cary, NC, USA).
esults
mong 6704 patients who presented with ACS, data were
uccessfully completed for 6638 patients. The mean PP,
BP, DBP and MAP were 56.5± 20, 139.8± 31, 83.5± 18 and
02± 20, respectively. Mean PP was lower in men compared
ith in women (55± 19 vs. 61± 22, P < 0.001) and in younger
ge compared with older age (53± 17 vs. 59± 21, P < 0.001).
able 1 describes patients’ characteristics in different PP
ubgroups. Among all PP groups, cardiovascular risk fac-
ors were less frequent in patients presenting with initial
ow PP, except for smoking and renal impairment. Patients
ith low PP were characterized by a higher resting heart
ate and higher Killip class on admission. In comparison with
igh PP, patients in the P1 group presented far more fre-
uently with STEMI (56% vs. 27%, P = 0.001), a higher level
f peak troponin T (23± 61 vs. 14± 53, P = 0.005) and a left
entricular ejection fraction < 40% (36% vs. 19%, P = 0.001).
atients in the P1 group were less likely to receive evidence-
ased medications and were less likely to undergo coronary
ngiography.
Tables 2 and 3 show the clinical presentation and hospital
utcomes in patients with NSTE-ACS and STEMI, stratiﬁed by
he initial PP values.
Correlation coefﬁcient analysis showed a signiﬁcant lin-
ar relationship among the BP variables i.e. PP and MAP
r = 0.54, 95% conﬁdence interval [CI] 0.51—0.55), SBP and
P (r = 0.81, 95% CI 0.80—0.83), DBP and PP (r = 0.24, 95%
I 0.22—0.30) and MAP and DBP (r = 0.95, 95% CI 0.94—0.96)
P < 0.001 for all).
Logistic regression multivariable analysis for in-hospital
utcomes showed that an initial low PP was associated with
worse in-hospital outcome than high PP. The mean PP in
atients who died after admission was lower than in those
ho survived (46± 22 vs. 57± 19mmHg, P < 0.001). In com-
arison with the P5 subgroup, lower PP subgroups had a
igniﬁcant association with higher mortality: P1, OR 9, 95%
I 5.78—13.35; P2, OR 3, 95% CI 1.71—4.06; P3, OR 1.5, 95%
I 1.01—2.49. After adjustment, low PP was associated with
igh rates of mortality (OR 7.5 [3.77—14.72]) and stroke (OR
.5 [1.20—18.88]) in ACS, a high rate of recurrent ischaemia
n NSTE-ACS (OR 2.8 [1.52—5.22]), and a high rate of HF in
TEMI (OR 2.1 [1.18—3.76]). Low SBP was associated with
imilar worse outcomes, although SBP was uniquely associ-
ted with a high rate of HF in NSTE-ACS and a high stroke rate
n STEMI (adjusted ORs 3 [1.57—5.92] and 14 [2.25—86.01],
espectively) (Table 4 and Fig. 1).
The mortality rate in the PP subgroups varied according
o the admission Killip class (Fig. 2). Even in the absence
f HF (i.e. Killip I); low PP was associated with greater
ortality compared with high PP. There was a signiﬁcant
ain effect for Killip class (P < 0.001) and PP (P < 0.001) on
ortality; the interaction between the two variables was
igniﬁcant (P for interaction = 0.001). Fig. 3 shows that apart
rom the P5 subgroup, women had a signiﬁcant higher crude
ortality rate when compared with that for men (P1, 19%
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Table 1 Clinical proﬁles, management and in-hospital outcomes in acute coronary syndrome patients.
PP≤ 30 PP 31—40 PP 41—50 PP 51—60 PP > 60 P
Number (%) 533 (8) 1244 (19) 1550 (23) 1241 (19) 2070 (31)
Demographics
Age 57± 14 54± 12 54± 12 56± 12 59± 12 0.001
Women (%) 24.0 18.8 20.4 22.8 31.7 0.001
Medical history
Diabetes (%) 35.6 32.9 36.5 40.8 50.8 0.001
Hypertension (%) 38.6 36.5 41.8 50.3 67.7 0.001
Dyslipidaemia (%) 23.8 26.2 30.4 32.4 38.7 0.004
Smokers (%) 41.5 44.9 41.5 39.1 29.8 0.001
Renal impairment (%) 26.9 16.9 14.9 14.0 20.3 0.001
Prior CAD (%) 46.7 40.3 43.5 45.7 50.6 0.001
Clinical characteristics
Peak troponin (ng/mL) 23± 61 21± 52 16± 45 16± 48 14± 53 0.005
Heart rate 88± 31 84± 23 85± 22 86± 22 87± 22 0.002
Systolic BP 97± 23 118± 17 131± 15 143± 19 169± 26 0.001
Diastolic BP 72± 22 79± 16 82± 15 86± 17 89± 20 0.001
MAP 81± 21 92± 16 99± 16 105± 19 117± 21 0.001
Body mass index 27± 5 27± 5 27± 5 28± 5 28± 6 0.009
Symptoms > 12 hours (%) 47.5 34.2 29.3 25.8 25.0 0.001
Killip > class 1 (%) 33 20 17 18 27 0.001
No typical angina (%) 23.1 17.2 16.7 19.5 24.0 0.001
LVEF < 40% (%) 36.3 24.3 20.8 21.7 19.3 0.001
Discharge diagnosis
NSTE-ACS (%) 44.2 48.6 59.8 63.3 72.8 0.001
STEMI (%) 55.8 51.4 40.2 36.7 27.2 0.001
Hospital treatments
Aspirin (%) 97.1 97.5 98.3 98.2 98.1 0.32
Clopidogrel (%) 48.3 55.0 56.4 53.9 52.6 0.01
GP IIb/IIIa inhibitor (%) 5.9 9.2 12.1 10.2 11.5 0.001
Beta-blockers (%) 48.1 62.2 69.4 68.9 66.5 0.001
Statins (%) 73.8 77.2 82.8 81.7 83.8 0.001
Heparin (%) 91.9 93.2 93.7 93.8 91.5 0.05
ACE inhibitors (%) 53.8 66.1 67.3 70.3 75.7 0.001
Coronary angiogram (%) 13.3 16.1 19.4 19.5 20.6 0.001
Hospital outcomes
Recurrent ischaemia (%) 11.6 11.2 8.1 8.3 8.0 0.002
Heart failure (%) 25.9 17.2 12.1 15.4 16.9 0.001
Cardiogenic shock (%) 20.9 6.6 3.2 2.4 2.6 0.001
Stroke (%) 2.2 0.6 0.4 0.5 0.8 0.001
Mortality (%) 14.7 4.5 2.7 1.7 1.7 0.001
All continuous variables are presented as mean± standard deviation. ACE: angiotensin-converting enzyme; BP: blood pressure; CAD: coro-
nary artery disease; GP: glycoprotein; LVEF: left ventricular ejection fraction; MAP: mean arterial pressure; NSTE-ACS: non-ST-segment
elevation acute coronary syndrome; PP: pulse pressure; STEMI: ST-segment elevation myocardial infarction.
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iscussionhe present study reported on the prognostic implications
f initial low PP in patients presenting with ACS in a multi-
ational, multicentre study. There are many key ﬁndings
M
o
i
wn this study. Firstly, in ACS, all BP variables were signif-
cantly correlated. Secondly, low PP was an independent
redictor of stroke and mortality in overall ACS. Although
P was not superior to SBP, only low PP was an indepen-
ent predictor of recurrent ischaemia in NSTE-ACS patients.
oreover, even in the absence of HF, low PP was a predictor
f in-hospital mortality in ACS patients. Thirdly, women with
nitial low PP had a greater crude mortality rate compared
ith their counterpart men (Fig. 3). There was a signiﬁcant
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Table 2 Clinical proﬁles and in-hospital outcomes according to pulse pressure at presentation in ST-segment elevation
myocardial infarction patients.
PP≤ 30 PP 31—40 PP 41—50 PP 51—60 PP > 60 P
Number (%) 299 (12) 639 (25) 623 (24) 454 (17) 563 (22)
Demographics
Age 56± 14 53± 12 53± 11 54± 12 56± 12 0.001
Women (%) 20 11 10 15 17 0.001
Clinical characteristics
Diabetes (%) 35 26 32 29 40 0.001
Hypertension (%) 29 26 28 35 51 0.001
Dyslipidaemia (%) 15 16.5 17.5 16 22 0.04
Smokers (%) 48 58 56 52.5 45 0.001
Peak troponin (ng/mL) 42± 82 40± 70 35± 68 36± 71 42± 88 0.66
Heart rate 84± 29 83± 21 85± 22 86± 22 86± 21 0.20
Systolic BP 96± 26 118± 18 131± 17 145± 19 168± 26 0.001
Diastolic BP 70± 22 79± 18 83± 16 88± 19 91± 20 0.001
MAP 79± 23 93± 18 99± 16 107± 19 117± 21 0.001
Body mass index 26± 5 27± 5 27± 5 27± 5 27± 5 0.09
Symptoms > 12 hours (%) 48 34 29 26 24 0.001
Killip > class 1 (%) 21.5 7.5 5 5 8 0.001
No typical angina 18 11 10 9 14 0.001
Low GRACE risk score 19 35 48 55 56 0.001
High GRACE risk score 56 30 20 19 18
LVEF < 40% 35 22 21 25 22 0.001
Hospital outcomes
Re-ischaemia (%) 9 12 6.4 8 10 0.01
Heart failure (%) 27 19 13 17 14 0.001
Cardiogenic shock (%) 28 9.5 5 6 6 0.001
Stroke (%) 3.5 1.1 0.5 0.7 1.4 0.001
Mortality (%) 20.5 6 3.5 3 4 0.001
All continuous variables are presented as mean± standard deviation. BP: blood pressure; GRACE: Global Registry of Acute Coronary
Events; LVEF: left ventricular ejection fraction; MAP: mean arterial pressure; PP: pulse pressure.
Figure 1. Clinical predictors of hospital mortality according to initial pulse pressure (PP). ACE: angiotensin-converting enzyme; LV: left
ventricular.
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Table 3 Clinical proﬁles and in-hospital outcomes according to pulse pressure at presentation in non-ST-segment ele-
vation acute coronary syndrome patients.
PP≤ 30 PP 31—40 PP 41—50 PP 51—60 PP > 60 P
Number (%) 234 (6) 605 (15) 927 (23) 787 (19) 1507 (37)
Demographics
Age 57± 14 56± 13 55± 12 57± 12 60± 12 0.001
Women (%) 29 27 27 27 37 0.001
Clinical characteristics
Diabetes (%) 36 40 39.5 47.5 55 0.001
Hypertension (%) 51 47 51 59 74 0.001
Dyslipidaemia (%) 34 36.5 39 42 45 0.001
Smokers (%) 34 31 32 31 24 0.001
Peak troponin (ng/mL) 5± 12 4± 10 4± 12 4± 21 4± 23 0.96
Heart rate 93± 32 85± 25 84± 22 86± 21 88± 22 0.001
Systolic BP 100± 20 117± 15 130± 16 142± 16 169± 26 0.001
Diastolic BP 75± 19 78± 15 82± 14 85± 15 88± 19 0.001
MAP 83± 18 91± 15 98± 14 104± 16 115± 20 0.001
Body mass index 27± 5 27± 5 28± 6 28± 5 28± 6 0.009
Symptoms > 12 hours (%) 25 33 60 12 44 0.06
Killip > class 1 (%) 30 19.5 17 19 28 0.001
No typical angina 30 23 21.5 25 28 0.004
Low GRACE risk score 18 30 39 46 45 0.001
High GRACE risk score 57 40 33 29 30
LVEF < 40% 39 28 21 19 18 0.001
Hospital outcomes
Re-ischaemia (%) 15 11 9 8 7 0.002
Heart failure (%) 25 15 11 14 18 0.001
Cardiogenic shock (%) 12 3.5 2 0.5 1.4 0.001
Stroke (%) 0.4 0.2 0.3 0.4 0.6 0.68
Mortality (%) 7 3 2 0.8 0.9 0.001
All continuous variables are presented as mean± standard deviation. BP: blood pressure; GRACE: Global Registry of Acute Coronary
Events; LVEF: left ventricular ejection fraction; MAP: mean arterial pressure; PP: pulse pressure.
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hain effect for female sex (P < 0.001) and PP (P < 0.001) on
ortality; the interaction between the two variables was
igniﬁcant (P interaction = 0.001). Fourthly, patients with
nitial low PP were less likely to receive evidence-based
herapy, including coronary intervention. Fifthly, initial low
P inversely correlated with GRACE risk score. Further-
ore, we assumed that poor prognosis in low PP groups
ould not be related only to low SBP and that low or nar-
ow PP may be of clinical and prognostic value in patients
ith apparently normal SBP (Fig. 2). The present study also
howed that low SBP was associated with similar worse
utcomes; however, SBP was uniquely associated with a
igh HF rate in NSTE-ACS patients and stroke rate in STEMI
atients (Table 4).
These ﬁndings may provoke debate, as most previous
tudies have suggested that high rather than low PP has a
oor prognosis [11—13]. However, previous studies were not
arried out on all the ACS subtypes and did not rely on mea-
uring PP on admission. Moreover, in most of these studies,
P was measured either at discharge or weeks after MI and
valuated post-discharge rather than in-hospital outcome
1—3,8,9,11—13,18—30]. A previous study reported that in
P
h
t
satients with ischaemic HF, high PP might be reﬂected in the
therosclerotic burden while low PP may be reﬂected in left
entricular dysfunction [27]. Low PP exclusively affected in-
ospital outcomes when it was measured on admission in
atients presenting with acute stress situations, while high
P had worse long-term outcome and high PP was mea-
ured in stable chronic cases [1,21,25,28,29]. Despite the
act that high PP may exacerbate myocardial ischaemia as
result of increased afterload and reduced coronary per-
usion, low PP may indicate low stroke volume, early sign
f cardiogenic shock in the acute cardiac events and may
e related to increased concentrations of natriuretic pep-
ides [3,27,31]. Petrie et al. studied 1959 patients within
he ﬁrst 21 days post MI and reported that only in high Killip
lasses (II—IV) did a low PP independently predict cardiovas-
ular mortality [26]. The current study expanded this ﬁnding
nd demonstrated that low initial PP was associated with
igher mortality in Killip classes I and II. Interestingly, low
P was associated with higher troponin values and resting
eart rate when compared with high PP groups. The latter
wo markers may partly explain the poor prognosis in our
tudy.
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Table 4 Unadjusted and adjusted predictors of hospital outcomes according to type of acute coronary syndrome.
Recurrent ischaemia Heart failure Stroke Mortality
Unadjusted Adjusteda Unadjusted Adjusteda Unadjusted Adjusteda Unadjusted Adjusteda
ACS
PP 1.5 (1.11—1.99) 1.3 (0.81—2.23) 1.8 (1.42—2.18) 1.5 (0.98—2.19) 2.8 (1.36—5.64) 4.5 (1.20—18.88) 9.0 (6.32—13.01) 7.5 (3.77—14.72)
SBP 1.6 (1.18—2.27) 1.2 (0.65—2.14) 4.3 (3.42—5.39) 3.3 (2.17—4.97) 5.0 (2.48—10.15) 8.0 (2.07—30.74) 17 (13.35—23.84) 8.4 (4.65—15.01)
NSTE-ACS
PP 1.8 (1.26—2.66) 2.8 (1.52—5.22) 1.8 (1.38—2.52) 1.2 (0.69—2.22) 0.97 (0.13—7.36) 2.8 (0.26—32.12) 5.3 (3.06—9.15) 7.1 (2.32—21.86)
SBP 1.9 (1.17—3.12) 2 (0.87—4.48) 3.3 (2.28—4.75) 3 (1.57—5.92) 2 (0.25—14.42) 4.3 (0.38—48.18) 14 (8.25—24.31) 5.8 (2.07—16.19)
STEMI
PP 0.95 (0.61—1.49) 0.4 (0.15—1.09) 2 (1.45—2.73) 2.1 (1.18—3.76) 2.7 (1.15—6.23) 7.7 (1.04—57.68) 5.3 (4.05—8.01) 6.7 (2.64—17.19)
SBP 1.5 (0.93—2.26) 0.7 (0.30—1.85) 5 (3.81—6.91) 3.4 (1.96—5.97) 4.8 (2.21—10.59) 14 (2.25—86.01) 15 (10.79—21.97) 8.5 (3.84—18.95)
Data are presented as odds ratios (95% conﬁdence intervals). ACS: acute coronary syndrome; NSTE-ACS: non-ST-segment elevation ACS, PP: pulse pressure ≤ 30mmHg; SBP: systolic blood
pressure < 100mmHg; STEMI: ST-segment elevation myocardial infarction.
a Adjusted for age, sex, diabetes, hypertension, aspirin, clopidogrel, beta-blockers, angiotensin-converting enzyme inhibitors, glycoprotein inhibitors, troponin T and ejection fraction.
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iﬁcantly correlated and had varying prognostic values.
lthough PP was not superior to SBP, low PP was of prognostic
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ent predictor for stroke and mortality in overall ACS. When
ompared with SBP, low PP was an independent predictor
or recurrent ischaemia in NSTE-ACS patients while low SBP
as independent predictor for HF in NSTE-ACS patients and
troke in STEMI patients. PP is a simple measure that could
e a part of risk scoring; however, prospective studies are
eeded to support our ﬁndings and to set an appropriate
anagement plan for these patients.
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